Evidence map›Paper›PMID 33535455›Full record

ReviewPlants (Basel, Switzerland)2021

Potential Application of Some Lamiaceae Species in the Management of Diabetes.

Ninon G E R Etsassala, Ahmed A Hussein, Felix Nchu

Abstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Seasonal Variation in WildMolecules (Basel, Switzerland) · 2026
    Article
  2. Targeting the vector of arbovirusesBeilstein journal of nanotechnology · 2025
    Review
  3. Hypoglycemic and Hypolipidemic Effects ofJournal of experimental pharmacology · 2025
    Article
  4. An Ethnopharmacological Survey on Medicinally Important Plants of Genus Salvia.Combinatorial chemistry & high throughput screening · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Aqueous extract ofJournal of diabetes and metabolic disorders · 2022
    Article
  12. Ameliorative Effect ofMolecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ninon G E R EtsassalaDepartment of Horticultural Sciences, Faculty of Applied Sciences, Cape Peninsula University of Technology, Symphony Road, Bellville 7535, South Africa.ORCID 0000-0002-6531-4102
Ahmed A HusseinChemistry Department, Cape Peninsula University of Technology, Bellville Campus, Symphony Road, Bellville 7535, South Africa.ORCID 0000-0002-3877-9959
Felix NchuDepartment of Horticultural Sciences, Faculty of Applied Sciences, Cape Peninsula University of Technology, Symphony Road, Bellville 7535, South Africa.ORCID 0000-0002-9910-5085

Funding

Cape Peninsula University of Technology URF R166
6 · The paper itself

Abstract

Diabetes is one of the most dangerous metabolic disorders, with high rates of mortality worldwide. Since ancient times, medicinal plants have been used in traditional medicine to treat many diseases, including diabetes and its related complications. Plants are widely accepted, affordable, and perceived to have minimal adverse side effects. The Lamiaceae family is a potential source of therapeutic agents for the management of metabolic disorders, including diabetes. Hence, this review paper summarizes the antidiabetic use of Lamiaceae species in folk medicine globally. Furthermore, we present the antidiabetic activities and phytochemical constituents of twenty-three (23) Lamiaceae species and the antidiabetic activity of some notable chemical constituents isolated from some of these Lamiaceae species.

Indexed as

diabetes mellitusLamiaceae speciesoxidative stresssecondary metabolites

Identifiers

PMID33535455
PMCPMC7912742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.